Despite many successes in 2023, the biotechnology industry saw a year-on-year decline in market capitalisation for the first time since 2012, according to GEN’s A-list. The largest biotech companies closed the year with a total market cap of $1.711 trillion, down 2.2% from the previous year. The decline reflects falling vaccine sales, increasing financial insecurity, and upcoming patent expiration for several major drugs.
Botnets leverage decade-old D-Link vulnerabilities in new attack campaigns
A new report from FortiGuard Labs has revealed the activities of two botnets, FICORA and CAPSAICIN, exploiting vulnerabilities in legacy D-Link devices. The report stresses